Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul-Aug;39(4):e70174.
doi: 10.1111/jvim.70174.

Long-Term Clinical Response to Medical Treatment, Behavioral Therapy, or Their Combination in Cats With Hyperesthesia Syndrome

Affiliations

Long-Term Clinical Response to Medical Treatment, Behavioral Therapy, or Their Combination in Cats With Hyperesthesia Syndrome

Claudia Pauciulo et al. J Vet Intern Med. 2025 Jul-Aug.

Abstract

Background: Hyperesthesia syndrome (HS) is a common yet poorly understood condition in cats, with hypothesized neurological and behavioral causes and limited data on outcomes and treatment.

Objectives: This study aimed to describe the clinical outcomes and the treatment response of 28 cats with HS, managed through various therapeutic strategies.

Animals: Clinical records of 28 cats with HS and minimum of 1-year follow-up were reviewed.

Methods: Retrospective, observational, descriptive study conducted on a case series of cats affected by HS. Sixteen cats (57%) received fluoxetine alone (Fluoxetine-only), seven (25%) were managed with behavioral modification and gabapentin or fluoxetine (Fluoxetine/Gabapentin + Behavior) and five (18%) were treated with behavioral modification alone (Behavior-only).

Results: An episode-free period (EFP) ≥ 9 months was observed in 23 (82%) cats. Fifteen cats (94%) in the Fluoxetine-only group experienced an EFP of ≥ 9 months. Moreover, they had a shorter time to recovery (median [IQR] = 8 [3.5-18] days) compared to the Fluoxetine/Gabapentin + Behavior and Behavior-only groups (median [IQR] = 100 [90-210] and 60 [30-90] days, respectively). At the 1-year follow-up, 26 (93%) cats no longer had HS clinical signs and 14 (50%) were still under pharmacotherapy. Relapses were reported only in one case (4%).

Conclusions: Most of the cat's diagnosed with HS, and managed through various therapeutic strategies, experienced an EFP of more than 9 months and showed absence of clinical signs at 1 year follow-up.

Keywords: behavioral modification; behavioral therapy; cats; feline; feline behavior; feline neurology; fluoxetine; hyperesthesia syndrome; rolling skin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Flowchart of case selection for the study population.

References

    1. Tuttle J., “Feline Hyperesthesia Syndrome,” Journal of the American Veterinary Medical Association 176, no. 1 (1980): 47. - PubMed
    1. Ciribassi J., “Feline Hyperesthesia Syndrome,” Compendium on Continuing Education for the Practicing Veterinarian 31, no. 3 (2009): 116–121.
    1. Munana K. R., “Feline Hyperesthesia Syndrome,” in Blackwell's Five‐Minute Veterinary Consult: Canine and Feline, 6th ed., ed. Tilley L. P. and Smith F. W. K. (John Wiley & Sons, Ltd, 2016), 497.
    1. Amengual Batle P., Rusbridge C., Nuttall T., Heath S., and Marioni‐Henry K., “Feline Hyperaesthesia Syndrome With Self‐Trauma to the Tail: Retrospective Study of Seven Cases and Proposal for an Integrated Multidisciplinary Diagnostic Approach,” Journal of Feline Medicine and Surgery 21, no. 2 (2019): 178–185, 10.1177/1098612X18764246. - DOI - PMC - PubMed
    1. Shell L. G., “Feline Hyperesthesia Syndrome,” Feline Practice 22, no. 6 (1994): 10–12.

LinkOut - more resources